The FDA proposed to make common prescription drugs, including those that treat diabetes, asthma and migraines, available over the counter in order to increase access to these medications. Proponents added the potential move could improve population health and proper medication use.
However, the AMA is taking a different stance, arguing the lack of physician involvement could lead to negative outcomes for patients. “Patients rely on physicians to provide sound diagnosis and treatment information and to help them meet their unique health needs” said Peter W. Carmel, MD, AMA president. “Expanding many prescription medications to OTC interferes with that important relationship without offering any real benefits to improve patients’ health or reduce their costs.”
Related Articles on Medication Safety:
Bill That Would Improve Drug, Medication Safety for Children Passes Senate Committee
CDC Issues Restatement on Single Dose, Single Use Vials
IOM Calls for Process to Improve Safety of Approved Drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
